Showing results (91-100 of 158) with videos related to

Sort By:
Pageof 16
Vaccine|February 13, 2001
Induction of antigen specific CD4+ T cell responses by invariant chain based DNA vaccinesE A van Tienhoven, C T ten Brink, J van Bergen, et al.
Clinical and Experimental Rheumatology|May 1, 1993
Heat-shock proteins and juvenile chronic arthritisE R de Graeff-Meeder, W van Eden, G T Rijkers, et al.
Experimental and Clinical Immunogenetics|January 1, 1984
HLA and the rubella-specific immune response following vaccinationW Van Eden, F UytdeHaag, H G Loggen, et al.
Immunology|February 1, 1994
Isolation and characterization of a cartilage-specific membrane antigen (CH65): comparison with cytokeratins and heat-shock proteinsH Bang, J Mollenhauer, A Schulmeister, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2000
T cell reactivity to heat shock protein 60 in diabetes-susceptible and genetically protected nonobese diabetic mice is associated with a protective cytokine profileA G van Halteren, B Mosselman, B O Roep, et al.
Clinical and Experimental Immunology|November 14, 1997
Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA)A Bloemendal, R Van der Zee, V P Rutten, et al.
Developmental and Comparative Immunology|June 27, 2008
ELISPOT and intracellular cytokine staining: novel assays for quantifying T cell responses in the chickenM P Ariaans, P M van de Haar, J W Lowenthal, et al.
European Journal of Immunology|May 1, 1991
T cell reactivity to an epitope of the mycobacterial 65-kDa heat-shock protein (hsp 65) corresponds with arthritis susceptibility in rats and is regulated by hsp 65-specific cellular responsesE J Hogervorst, C J Boog, J P Wagenaar, et al.
Immunological Reviews|February 1, 1996
(Altered) self peptides and the regulation of self reactivity in the peripheral T cell poolW Van Eden, S M Anderton, R Van Der Zee, et al.
European Journal of Immunology|December 1, 1996
Inhibition of experimental autoimmune myasthenia gravis by major histocompatibility complex class II competitor peptides results not only in a suppressed but also in an altered immune responseM H Wauben, A C Hoedemaekers, Y M Graus, et al.
Pageof 16